Assessment of of the biological effects of curcumin on microbiota in children with acute lymphoblastic leukemia
Assessment of the safety of curcumin, which is the most active constituent of the ground rhizome of the Curcuma longa plant, in children with acute lymphoblastic leukemia patients (ALL) in maintenance phase of chemotherapy through the assessment of the any reported adverse event (AE). And assessment of the curcumin effect on health by eliminating intestinal microflora dysbiosis
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
30
Tumeric curcumin 500 mg per oral capsule of Puritans Pride company supplement
As per institution protocol for Standard of nutritional Care
Pediatric Hematology Oncology and BMT Unit, Faculty of Medicine Ain Shams University
Cairo, Non-US, Egypt
Determine the Safety of curcumin in pediatric patients with ALL.
Percentage of patients who developed adverse event
Time frame: 4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.